Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Clinical use of tyrosine kinase inhibitors for chronic myeloid leukemia


Robert S Negrin, MD

Section Editor — Bone Marrow Transplantation

Professor of Medicine

Stanford University School of Medicine

Charles A Schiffer, MD

Professor of Medicine and Oncology

Barbara Ann Karmanos Cancer Institute

Wayne State University School of Medicine

Section Editor

Richard A Larson, MD

Editor-in-Chief — Hematology

Section Editor — Leukemia

Professor of Medicine

University of Chicago Pritzker School of Medicine

Deputy Editor

Alan G Rosmarin, MD

Deputy Editor — Hematology

Professor of Medicine

University of Massachusetts Medical School

Peer Reviewer

Reviewers are not identified on topic reviews to preserve anonymity